Skip to main content

Table 1 Clinical and demographic characteristics of all GCs (n = 333)

From: Intravenous sedation during esophagogastroduodenoscopy is associated with a reduced risk of missed gastric cancer

 

Non-MGC (n = 313)

MGC (N = 20)

p

Sex; Male; n (%)

207 (66.1)

14 (70)

0.723

Age; mean (SD)

70 (14.1)

71.7 (10.5)

0.598

Alarm symptoms; n (%)

231 (73.8)

6 (30)*

0.001

 

231 (73.8)

14(70)**

0.708

Histology; n (%)

  

0.130

 Adenocarcinoma

277 (88.4)

18 (90)

 

 Lymphoma

26 (8.3)

0 (0)

 

 GIST

10 (3.3)

2 (10)

 

Location; n (%)

  

0.001

 Body-antrum

235 (75.1)

10 (50)

0.014

 Cardia-fundus

66 (21)

5 (25)

0.348

 Anastomosis

3 (1)

3 (15)

0.001

 Diffuse

9 (2.9)

2 (10)

0.084

SmokersΔ; n

269

18

0.375

Yes, n (%)

106 (39.4)

9 (50)

 

No, n (%)

163 (60.6)

9 (50)

 

Intestinal metaplasiaΔ; n

277

11

0.841

Yes, n (%)

207 (74.7)

8 (72.7)

 

No, n (%)

70 (25.3)

3 (27.3)

 
  1. GC = gastric cancer; MGC = missed gastric cancer; SD = standard deviation; GIST = gastrointestinal stromal tumour
  2. *Alarm symptoms at the time of negative endoscopy
  3. **Alarm symptoms at the time of diagnostic endoscopy
  4. Diffuse and intestinal adenocarcinomas (Lauren classification)
  5. ΔInformation on all patients was not available
  6. Only for adenocarcinomas